Status:
UNKNOWN
Patching or Gaming as Amblyopia Treatment?
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
Lijf & Leven
ODAS Stichting
Conditions:
Amblyopia
Eligibility:
All Genders
4-55 years
Phase:
NA
Brief Summary
Amblyopia affects 3% of the children and is caused by strabismus, anisometropia or both. Standard treatment is glasses and patching therapy. From North-America, behavioural training, i.e. dichoptic tr...
Detailed Description
Amblyopia affects 3% of the children and is caused by strabismus, anisometropia or both. The standard treatment is glasses and patching therapy. From North-America, behavioural training, i.e. dichopti...
Eligibility Criteria
Inclusion
- Amblyopia; an interocular difference in visual acuity of at least 2 logMAR lines.
Exclusion
- A non-comitant or large angle constant strabismus \>30Prism Dioptres, a neurological disorder, nystagmus, other eye disorders and diminished acuity due to medication, brain damage or trauma.
Key Trial Info
Start Date :
December 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT03767985
Start Date
December 18 2017
End Date
December 31 2021
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus Medical Center
Rotterdam, South Holland, Netherlands, 3015 GD